کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9917650 | 1556306 | 2005 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: Implications of metabolism and regional deposition
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
CmaxVirginia Commonwealth UniversityFD-4IPRLModel selection criterionVCUUSPMDINIHtmaxRIAMSCN-ethylmaleimideANPAPNPBSBSA - BSABAC - LACRadio immunoassay - آزمایش ایمنی رادیوییbovine serum albumin - آلبومین سرم گاوAminopeptidase N - آمینوپپتیداز Ninsulin degrading enzyme - آنزیم تحقیر کننده انسولینinsulin - انسولینenzyme immunoassay - ایمونواسی آنزیم EIA - اینIDE - اینجاBacitracin - باسیتراسینMucociliary clearance - ترخیص موکوسیلیارELISA - تست الیزاEnzyme-linked immunosorbent assay - تست الیزاAbsorption - جذبMetered Dose Inhaler - دز انالایزر اندازه گیری شدهDeposition - رسوبLung - ریهcoefficient of determination - ضریب تعیینPharmacokinetics - فارماکوکینتیکMetabolism - متابولیسم Phosphate-buffered saline - محلول نمک فسفات با خاصیت بافریNational Institute of Health - موسسه ملی بهداشتNEM - نهatrial natriuretic peptide - پپتید نایروئیدوری دهلیزCod - کادو
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: Implications of metabolism and regional deposition The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: Implications of metabolism and regional deposition](/preview/png/9917650.png)
چکیده انگلیسی
The pharmacokinetics of several lung disposition pathways for pulmonary insulin were studied and modeled in the isolated perfused rat lung (IPRL). Insulin solution was administered by forced instillation into the airways of the IPRL as 0.1 or 0.02 ml doses of coarse spray, with or without bacitracin (BAC), N-ethylmaleimide (NEM) and atrial natriuretic peptide (ANP). Each insulin absorption profile was fitted to a kinetic model that incorporated the distribution fraction of the dose reaching the lobar region (DF) and the rate constants for absorption into perfusate (ka) and non-absorptive loss (knal); knal was shown to be due to the sum of mucociliary clearance and metabolism. Insulin absorption occurred largely by passive diffusion with values for ka = 0.39-0.50 hâ1. With DF = 0.91 following 0.1 ml doses, 11.9 ± 3.4% of bioavailabilities were observed in 1 h. In contrast, derived values for knal = 2.34-3.45 hâ1 were significantly larger than the rate constant for mucociliary clearance determined previously in this IPRL (0.96-1.74 hâ1) due to lung metabolism. Indeed, BAC, but neither NEM nor ANP, was found to decrease the value of knal, which suggested that BAC-inhibitable lung ectopeptidases, and not insulin degrading enzyme (IDE), were responsible for this pulmonary metabolism. Shallower lung distribution with DF = 0.73 following 0.02 ml doses resulted in reduced values for ka = 0.27 hâ1 and knal = 2.79 hâ1, indicating that these kinetic processes may be lung-region dependent, even within this model and emphasizing the likely importance of reliable lung deposition in vivo.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutical Sciences - Volume 25, Issues 4â5, JulyâAugust 2005, Pages 369-378
Journal: European Journal of Pharmaceutical Sciences - Volume 25, Issues 4â5, JulyâAugust 2005, Pages 369-378
نویسندگان
Yinuo Pang, Masahiro Sakagami, Peter R. Byron,